Cargando…

Impact of Elevated LDH on Cystatin C-Based Glomerular Filtration Rate Estimates in Patients with Cancer

Background: The determination of renal function is crucial for the clinical management of patients with cancer. The glomerular filtration rate (GFR) serves as a key parameter, estimated by creatinine clearance determination in 24-h collected urine (CrCl) as well as equation-based approaches (eGFR) r...

Descripción completa

Detalles Bibliográficos
Autores principales: Aydilek, Enver, Wallbach, Manuel, Koziolek, Michael, Wulf, Gerald Georg, Brökers, Nils
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503681/
https://www.ncbi.nlm.nih.gov/pubmed/36143104
http://dx.doi.org/10.3390/jcm11185458
_version_ 1784796025998802944
author Aydilek, Enver
Wallbach, Manuel
Koziolek, Michael
Wulf, Gerald Georg
Brökers, Nils
author_facet Aydilek, Enver
Wallbach, Manuel
Koziolek, Michael
Wulf, Gerald Georg
Brökers, Nils
author_sort Aydilek, Enver
collection PubMed
description Background: The determination of renal function is crucial for the clinical management of patients with cancer. The glomerular filtration rate (GFR) serves as a key parameter, estimated by creatinine clearance determination in 24-h collected urine (CrCl) as well as equation-based approaches (eGFR) relying on serum creatinine (eGFR CKD EPIcrea) or serum cystatin C (eGFR cystatin C). Serum creatinine and serum cystatin C levels differentially depend on muscle and tumor mass, respectively. Although muscle and tumor mass may thus represent confounding factors, comparative studies for eGFR estimate approaches in cancer patients are lacking. Methods: The present study retrospectively analyzed GFR estimates based on equations of creatinine (eGFRcr), cystatin C (eGFRcys) and combined creatinine-cystatin C levels (eGFRcr-cys) in a subset of patients. The associations of LDH with cystatin C or LDH with eGFRcr, eGFRcys and GFRcr-cys were explored. Results: The laboratory values of 123 consecutive patients were included. The median age was 59 (24–87) and 47.2% were female. There was a statistically significant difference in the mean of CKD EPIcrea (85.17 ± 21.63 mL/min/1.73 m(2)), CKD EPIcys (61.16 ± 26.03 mL/min/1.73 m(2)) and CKD EPIcrea-cys (70.42 ± 23.89 mL/min/1.73 m(2)) (p < 0.0001). Spearman’s correlation analysis revealed a significant correlation of elevated plasma LDH >1.5 UNV and cystatin C values (r = 0.270, p < 0.01, n = 123). LDH values >1.5 UNV were associated with significantly lower CKD EPIcys (r = 0.184, p < 0.01) or CKD EPIcrea-cys (r = 0.226, p < 0.05) estimates compared to CKD EPIcrea. Conclusions: The inclusion of cystatin C as a biomarker led to a lower eGFR estimates compared to creatinine alone or in a combination of both cystatin C and creatinine. The level of cystatin C correlated with the level of LDH, suggesting that the use of cystatin C-based calculations of GFR in cancer patients with elevated LDH should be used with caution.
format Online
Article
Text
id pubmed-9503681
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95036812022-09-24 Impact of Elevated LDH on Cystatin C-Based Glomerular Filtration Rate Estimates in Patients with Cancer Aydilek, Enver Wallbach, Manuel Koziolek, Michael Wulf, Gerald Georg Brökers, Nils J Clin Med Article Background: The determination of renal function is crucial for the clinical management of patients with cancer. The glomerular filtration rate (GFR) serves as a key parameter, estimated by creatinine clearance determination in 24-h collected urine (CrCl) as well as equation-based approaches (eGFR) relying on serum creatinine (eGFR CKD EPIcrea) or serum cystatin C (eGFR cystatin C). Serum creatinine and serum cystatin C levels differentially depend on muscle and tumor mass, respectively. Although muscle and tumor mass may thus represent confounding factors, comparative studies for eGFR estimate approaches in cancer patients are lacking. Methods: The present study retrospectively analyzed GFR estimates based on equations of creatinine (eGFRcr), cystatin C (eGFRcys) and combined creatinine-cystatin C levels (eGFRcr-cys) in a subset of patients. The associations of LDH with cystatin C or LDH with eGFRcr, eGFRcys and GFRcr-cys were explored. Results: The laboratory values of 123 consecutive patients were included. The median age was 59 (24–87) and 47.2% were female. There was a statistically significant difference in the mean of CKD EPIcrea (85.17 ± 21.63 mL/min/1.73 m(2)), CKD EPIcys (61.16 ± 26.03 mL/min/1.73 m(2)) and CKD EPIcrea-cys (70.42 ± 23.89 mL/min/1.73 m(2)) (p < 0.0001). Spearman’s correlation analysis revealed a significant correlation of elevated plasma LDH >1.5 UNV and cystatin C values (r = 0.270, p < 0.01, n = 123). LDH values >1.5 UNV were associated with significantly lower CKD EPIcys (r = 0.184, p < 0.01) or CKD EPIcrea-cys (r = 0.226, p < 0.05) estimates compared to CKD EPIcrea. Conclusions: The inclusion of cystatin C as a biomarker led to a lower eGFR estimates compared to creatinine alone or in a combination of both cystatin C and creatinine. The level of cystatin C correlated with the level of LDH, suggesting that the use of cystatin C-based calculations of GFR in cancer patients with elevated LDH should be used with caution. MDPI 2022-09-16 /pmc/articles/PMC9503681/ /pubmed/36143104 http://dx.doi.org/10.3390/jcm11185458 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Aydilek, Enver
Wallbach, Manuel
Koziolek, Michael
Wulf, Gerald Georg
Brökers, Nils
Impact of Elevated LDH on Cystatin C-Based Glomerular Filtration Rate Estimates in Patients with Cancer
title Impact of Elevated LDH on Cystatin C-Based Glomerular Filtration Rate Estimates in Patients with Cancer
title_full Impact of Elevated LDH on Cystatin C-Based Glomerular Filtration Rate Estimates in Patients with Cancer
title_fullStr Impact of Elevated LDH on Cystatin C-Based Glomerular Filtration Rate Estimates in Patients with Cancer
title_full_unstemmed Impact of Elevated LDH on Cystatin C-Based Glomerular Filtration Rate Estimates in Patients with Cancer
title_short Impact of Elevated LDH on Cystatin C-Based Glomerular Filtration Rate Estimates in Patients with Cancer
title_sort impact of elevated ldh on cystatin c-based glomerular filtration rate estimates in patients with cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503681/
https://www.ncbi.nlm.nih.gov/pubmed/36143104
http://dx.doi.org/10.3390/jcm11185458
work_keys_str_mv AT aydilekenver impactofelevatedldhoncystatincbasedglomerularfiltrationrateestimatesinpatientswithcancer
AT wallbachmanuel impactofelevatedldhoncystatincbasedglomerularfiltrationrateestimatesinpatientswithcancer
AT koziolekmichael impactofelevatedldhoncystatincbasedglomerularfiltrationrateestimatesinpatientswithcancer
AT wulfgeraldgeorg impactofelevatedldhoncystatincbasedglomerularfiltrationrateestimatesinpatientswithcancer
AT brokersnils impactofelevatedldhoncystatincbasedglomerularfiltrationrateestimatesinpatientswithcancer